Funding · Company
Osteal Therapeutics, Inc.
Dallas, TXBiotech & Pharma
Osteal Therapeutics, Inc. of Dallas, TX has disclosed $103M across 3 Form D offerings filed with the SEC between Dec 30, 2021 and Jun 6, 2024.
$103M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$50M
Form D · Jun 6, 2024 ↗
Q2 2024
· target $50M
$22M
Form D · Sep 12, 2023 ↗
Q3 2023
· target $23M
$30M
Form D · Dec 30, 2021 ↗
Q4 2021
· target $32M
Filing details
HeadquartersDallas, TXIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001735936Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →